Autopsy report · NCT03464604
Melanoma Accuracy Study; Phase 2
Cause of deathStaffing, sites or logistics, also slow enrollment
“COVID forced the termination of this study. No impact on participants already enrolled.”
Life of this trial
- Ran for about 7 months before it stopped.
- 121 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Nova Scotia Health Authority
- Sponsor type
- University, hospital or other
- Conditions
- Melanoma
- Interventions
- active
- Participants
- 121
- Sites
- 2
- Countries
- Canada
Trials that died the same way
- Effects of Community-center Based Dietary Intervention on Frailty Prevention and Regression in the Elderly.
“Due to the impacts of COVID-19, the study had to terminate.” - Changing Developmental Trajectories Through Early Treatment
“Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.” - Treatment Resistance Following Anti-cancer Therapies
“Study terminated due to lack of enrollment that has been compounded by the global COVID-19 pandemic. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.” - Evaluating Emetine for Viral Outbreaks (EVOLVE)
“The study was terminated due to insufficient participant enrollment resulting from a lower-than-expected number of COVID-19 cases” - Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)
“The study was stopped due to slower than expected recruitment and the additional limitations on clinical research imposed by the COVID-19 pandemic, both of which made study completion within a reasonable timeframe appear unlikely.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.